Department of Neurology

Print Friendly

Director, Parkinson's Disease & Movement Disorders Center

Clinical Chair, Signature Interdisciplinary Program in Neuroscience

USF Health Byrd Institute
4001 Fletcher Avenue
6th Floor
Tampa, FL 33613

USF Mail Stop: MDC55

For patients:
(813) 396-0751

Fax: (813) 905-9829
Email: rhauser@health.usf.edu

Robert A. Hauser, M.D., M.B.A.

Movement Disorders
Professor

Education

Medical School: Temple University School of Medicine
Residency: Eastern Virginia Graduate School of Medicine (Neurology)
Fellowship: University of South Florida, College of Medicine under C.W. Olanow, M.D. (Movement Disorders)

Interests

Clinical Interests:
Dr. Hauser provides expert evaluation and care for individuals with Parkinson's disease and other movement disorders including Parkinsonism, tremor, chorea, dystonia, and restless legs syndrome. Patients may be offered the opportunity to participate in clinical trials and information gained from these trials is utilized to provide cutting edge therapy for patients. Dr. Hauser is an authority on botulinum toxin injections for the treatment of movement disorders, having performed such injections for over 20 years. Botulinum toxin injections are provided for a variety of disorders including cervical dystonia, blepharospasm, hemifacial spasm, and other involuntary movements.

Research Interests:
Dr. Hauser's research focuses on the development of new treatments for Parkinson's disease and other movement disorders including essential tremor, cervical dystonia, blepharospasm, hemifacial spasm, Huntington's disease, and restless legs syndrome. His expertise includes clinical trial design and execution. Dr. Hauser is the lead investigator for several national and international clinical trials and he serves on steering committees for multiple drug development programs and individual clinical trials. Developing medications to slow or stop the progression of neurodegenerative disorders is a top priority.

Board Certification(s):
•American Board of Psychiatry & Neurology (Neurology)
•American Society of Neuroimaging (MRI - Magnetic Resonance Imaging)

Specialties:
• Movement Disorders including Parkinson's Disease
• Parkinsonism
• Tremor
• Cervical Dystonia
• Blepharospasm
• Hemifacial Spasm
• Huntington's Disease
• Restless Legs Syndrome
• Tardive Dyskinesia
• Myoclonus
• Ataxia

Specialties:
Dr. Hauser has authored or co-authored more than 150 peer-reviewed publications and has lectured frequently at scientific meetings around the world. He is Past Chairman of the Interventional Neurology Section of the American Academy of Neurology, has served on the executive committee of the Parkinson Study Group, and is a member of the steering committee for the NIH (National Institutes of Health) Neuroprotective Exploratory Trials in Parkinson's Disease Program (NET-PD). Dr. Hauser serves as an international leader in the advancement of disease management and utilizes this knowledge to provide the highest quality care to patients, and to educate students, residents, and other physicians.

Dr. Hauser is one of 10 neurologists in Florida to be named in U.S. News and World Report to a highly selective list of America’s Top Doctor’s by achieving national recognition for outstanding work. He is considered to be in the top 1% in the nation in his specialty.

Selected Publications

IPX066: a novel carbidopa-levodopa extended-release formulation
Hauser RA. Expert Rev Neurother. 2012;12(2):133-40.

The UPDRS-8: A Brief Clinical Assessment Scale for Parkinson's Disease.
Hauser RA, Lyons KE, Pahwa R. Int J Neurosci. 2012

Future treatments for Parkinson’s disease: surfing the PD pipeline.
Hauser RA. Int J Neurosci. 2011;121(Suppl 2):53-62.

Determination of minimal clinically important change in early and advanced Parkinson's disease.
Hauser RA, Auinger P; on behalf of the Parkinson Study Group. Mov Disord. 2011 Apr;26(5):813-818. doi: 10.1002/mds.23638. Epub 2011 Mar 24. PMID: 21437987 [PubMed - as supplied by publisher]

[(123) I]FP-CIT (DaTscan) SPECT Brain Imaging in Patients with Suspected Parkinsonian Syndromes.
Hauser RA, Grosset DG. J Neuroimaging. 2011 Mar 16. doi: 10.1111/j.1552-6569.2011.00583.x. [Epub ahead of print] PMID: 21410815 [PubMed - as supplied by publisher]

Preladenant in patients with Parkinson's disease and motor fluctuations: a phase 2, double-blind, randomised trial.
Hauser RA, Cantillon M, Pourcher E, Micheli F, Mok V, Onofrj M, Huyck S, Wolski K. Lancet Neurol. 2011 Mar;10(3):221-9. PMID: 21315654 [PubMed - indexed for MEDLINE] Related citations

Levodopa response in early Parkinson's disease.
Hauser RA, Auinger P, Oakes D; Parkinson Study Group. Mov Disord. 2009 Dec 15;24(16):2328-36. PMID: 19908302 [PubMed - indexed for MEDLINE] Related citations

Levodopa: past, present, and future.
Hauser RA. Eur Neurol. 2009;62(1):1-8. Epub 2008 Sep 9. Review. PMID: 19407449 [PubMed - indexed for MEDLINE] Related citations